Cellular Health Screening/Health Testing Market by Type (Single (Telomere, Oxidative Stress, Inflammation, Heavy Metal), Multitest), Sample (Blood, Saliva, Serum, Urine), Collection Site (Home, Office, Hospital, Diagnostic Labs), and Region - Global Forecast to 2022
“Cellular health screening market projected to grow at a CAGR of 10.0% from 2017 to 2022.”
The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are driving the growth of the global cellular health screening market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies may hinder the growth of the market in the coming years.
“The multi-test panels are expected to witness high growth during the forecast period.”
Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. Multi-test panels are expected to register the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.
“Blood samples to dominate the global cellular health screening market in 2017.”
Based on sample type, the global cellular health screening market is segmented into blood samples and other samples. The blood samples segment is expected to dominate this market with the largest share in 2017. The large share and high growth of this segment can primarily be attributed to the advantages associated with the use of blood samples, such as the accuracy and reliability of test results.
“North America to dominate the market and Asia to witness high growth during the forecast period.”
In 2017, North America is expected to account for the largest share of the global cellular health screening market. Factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region are supporting the growth of the global cellular health screening market in the region. Also, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the rising geriatric population, increasing burden of chronic diseases, expansion opportunities for market players, and growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.
The primary interviews conducted for this report can be categorized as follows:
The report provides an overview of the global cellular health screening market. It aims at estimating the market size and future growth potential of this market across different segments such as type, sample type, sample collection sites, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global cellular health screening market and its subsegments. This report will help stakeholders to understand the competitor landscape better and gain insights to position their businesses better and make suitable go-to-market strategies. The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities.
The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are driving the growth of the global cellular health screening market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies may hinder the growth of the market in the coming years.
“The multi-test panels are expected to witness high growth during the forecast period.”
Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. Multi-test panels are expected to register the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.
“Blood samples to dominate the global cellular health screening market in 2017.”
Based on sample type, the global cellular health screening market is segmented into blood samples and other samples. The blood samples segment is expected to dominate this market with the largest share in 2017. The large share and high growth of this segment can primarily be attributed to the advantages associated with the use of blood samples, such as the accuracy and reliability of test results.
“North America to dominate the market and Asia to witness high growth during the forecast period.”
In 2017, North America is expected to account for the largest share of the global cellular health screening market. Factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region are supporting the growth of the global cellular health screening market in the region. Also, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the rising geriatric population, increasing burden of chronic diseases, expansion opportunities for market players, and growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 36%; Tier 2 - 41%; Tier 3 - 23%.
- By Designation (Supply Side): C-level- 46%; D-level- 29%; Others- 25%.
- By Region: North America–40%; Europe-20%; Asia-33%; RoW-7%.
- Genova Diagnostics
- Telomere Diagnostics
- Life Length
- Quest Diagnostics
- Repeat Diagnostics
- SpectraCell Laboratories
- Zimetry LLC
- Cell Science Systems
- Titanovo, Inc.
- Segterra, Inc.
- LabCorp Holdings
- BioReference Laboratories
- Immundiagnostik AG
- Cleveland HeartLab, Inc.
- DNA Labs India
The report provides an overview of the global cellular health screening market. It aims at estimating the market size and future growth potential of this market across different segments such as type, sample type, sample collection sites, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global cellular health screening market and its subsegments. This report will help stakeholders to understand the competitor landscape better and gain insights to position their businesses better and make suitable go-to-market strategies. The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.2 PRIMARY DATA
2.3 KEY INDUSTRY INSIGHTS
2.4 MARKET SIZE ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CELLULAR HEALTH SCREENING MARKET: MARKET OVERVIEW
4.2 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017–2022
4.3 CELLULAR HEALTH SCREENING MARKET, BY TYPE
4.4 CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS (2017)
4.5 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE
4.6 GEOGRAPHIC SNAPSHOT OF THE CELLULAR HEALTH SCREENING MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of telomere performance programs for leading a healthy life
5.2.1.2 Growing importance of healthy life expectancy (HALE)
5.2.1.3 Rising government focus towards preventive healthcare
5.2.1.4 Rising geriatric population and resultant growth in the need for cellular health screening
5.2.1.5 Increasing research activities
5.2.1.6 Growing adoption of direct-to-consumer approach for the availability of kits
5.2.1.7 Increasing burden of chronic diseases
5.2.2 RESTRAINTS
5.2.2.1 Problems associated with the transport of samples
5.2.2.2 Differences in the cost of test kits offered by different companies
5.2.3 OPPORTUNITIES
5.2.3.1 Potential applications of cellular health screening in precision and personalized medicine
5.2.3.2 Expansion in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Limited reimbursement
5.2.5 TRENDS
5.2.5.1 Adoption of digital technologies for testing
5.2.5.2 Label-free detection technologies are set to transform the market
5.2.5.3 NGS-based Telomere length measurement techniques
6 CELLULAR HEALTH SCREENING MARKET, BY TYPE
6.1 INTRODUCTION
6.2 SINGLE TEST PANELS
6.2.1 TELOMERE TESTS
6.2.2 OXIDATIVE STRESS TESTS
6.2.3 INFLAMMATION TESTS
6.2.4 HEAVY METALS TESTS
6.3 MULTI-TEST PANELS
7 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE
7.1 INTRODUCTION
7.2 BLOOD SAMPLES
7.3 OTHER SAMPLES
8 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE
8.1 INTRODUCTION
8.2 AT-HOME SAMPLE COLLECTION
8.3 IN-OFFICE SAMPLE COLLECTION
8.4 OTHER SITES
9 CELLULAR HEALTH SCREENING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic diseases
9.2.1.2 Increasing initiatives for preventive healthcare
9.2.1.3 Presence of major market players in the U.S.
9.2.2 CANADA
9.2.2.1 Government initiatives to promote a healthy lifestyle
9.2.2.2 Growing research activities
9.3 EUROPE
9.3.1 INCREASING BURDEN OF CHRONIC DISEASES
9.3.2 INITIATIVES TO CREATE AWARENESS ABOUT CELLULAR BIOMARKERS
9.3.3 INITIATIVES BY GOVERNMENTS AND MAJOR MARKET PLAYERS
9.4 ASIA
9.4.1 RISING GERIATRIC POPULATION AND INCREASING BURDEN OF
CHRONIC DISEASES
9.4.2 EXPANSION OPPORTUNITIES FOR MARKET PLAYERS
9.4.3 INITIATIVES TO CREATE AWARENESS ON HEALTHY LIFESTYLES AND PREVENTIVE HEALTHCARE
9.5 REST OF THE WORLD
9.5.1 GROWING PREVALENCE OF CHRONIC DISEASES
9.5.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
9.5.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPANY RANKING: TELOMERE TESTING MARKET
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE BENCHMARKING
10.4.1 BUSINESS STRATEGIES EXCELLENCE
10.4.2 STRENGTH OF PRODUCT PORTFOLIO
*Top 25 companies analyzed for this study are - Genova Diagnostics; Quest Diagnostics; Life Length; Zimetry LLC; Telomere Diagnostics; Repeat Diagnostics; SpectraCell Laboratories; Cell Science Systems; Titanovo, Inc.; InsideTracker; DNA LABS India; Laboratory Corporation of America Holdings; Cleveland HeartLab, Inc.; BioReference Laboratories; Immundiagnostik AG; Spectra Laboratories; Cell Biolabs Inc.; AML Diagnostics; Enzo Clinical Lab; Access Medical Labs; Life Line Screening; Mayo Medical Laboratories; Clinical Reference Labotory; Synlab Internatinal; ACM Medical Laboratory
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships)*
11.1 TELOMERE DIAGNOSTICS, INC. (TDX)
11.2 SPECTRACELL LABORATORIES
11.3 LIFE LENGTH
11.4 REPEAT DIAGNOSTICS INC. (REPEAT DX)
11.5 TITANOVO
11.6 CELL SCIENCE SYSTEMS
11.7 QUEST DIAGNOSTICS
11.8 LABCORP HOLDINGS
11.9 BIOREFRENCE LABORATORIES
11.10 CLEVELAND HEARTLAB, INC.
11.11 GENOVA DIAGNOSTICS
11.12 ZIMETRY LLC
11.13 IMMUNDIAGNOSTIK AG
11.14 SEGTERRA, INC.
11.15 DNA LABS INDIA
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.2 PRIMARY DATA
2.3 KEY INDUSTRY INSIGHTS
2.4 MARKET SIZE ESTIMATION
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CELLULAR HEALTH SCREENING MARKET: MARKET OVERVIEW
4.2 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017–2022
4.3 CELLULAR HEALTH SCREENING MARKET, BY TYPE
4.4 CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS (2017)
4.5 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE
4.6 GEOGRAPHIC SNAPSHOT OF THE CELLULAR HEALTH SCREENING MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of telomere performance programs for leading a healthy life
5.2.1.2 Growing importance of healthy life expectancy (HALE)
5.2.1.3 Rising government focus towards preventive healthcare
5.2.1.4 Rising geriatric population and resultant growth in the need for cellular health screening
5.2.1.5 Increasing research activities
5.2.1.6 Growing adoption of direct-to-consumer approach for the availability of kits
5.2.1.7 Increasing burden of chronic diseases
5.2.2 RESTRAINTS
5.2.2.1 Problems associated with the transport of samples
5.2.2.2 Differences in the cost of test kits offered by different companies
5.2.3 OPPORTUNITIES
5.2.3.1 Potential applications of cellular health screening in precision and personalized medicine
5.2.3.2 Expansion in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Limited reimbursement
5.2.5 TRENDS
5.2.5.1 Adoption of digital technologies for testing
5.2.5.2 Label-free detection technologies are set to transform the market
5.2.5.3 NGS-based Telomere length measurement techniques
6 CELLULAR HEALTH SCREENING MARKET, BY TYPE
6.1 INTRODUCTION
6.2 SINGLE TEST PANELS
6.2.1 TELOMERE TESTS
6.2.2 OXIDATIVE STRESS TESTS
6.2.3 INFLAMMATION TESTS
6.2.4 HEAVY METALS TESTS
6.3 MULTI-TEST PANELS
7 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE
7.1 INTRODUCTION
7.2 BLOOD SAMPLES
7.3 OTHER SAMPLES
8 CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE
8.1 INTRODUCTION
8.2 AT-HOME SAMPLE COLLECTION
8.3 IN-OFFICE SAMPLE COLLECTION
8.4 OTHER SITES
9 CELLULAR HEALTH SCREENING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic diseases
9.2.1.2 Increasing initiatives for preventive healthcare
9.2.1.3 Presence of major market players in the U.S.
9.2.2 CANADA
9.2.2.1 Government initiatives to promote a healthy lifestyle
9.2.2.2 Growing research activities
9.3 EUROPE
9.3.1 INCREASING BURDEN OF CHRONIC DISEASES
9.3.2 INITIATIVES TO CREATE AWARENESS ABOUT CELLULAR BIOMARKERS
9.3.3 INITIATIVES BY GOVERNMENTS AND MAJOR MARKET PLAYERS
9.4 ASIA
9.4.1 RISING GERIATRIC POPULATION AND INCREASING BURDEN OF
CHRONIC DISEASES
9.4.2 EXPANSION OPPORTUNITIES FOR MARKET PLAYERS
9.4.3 INITIATIVES TO CREATE AWARENESS ON HEALTHY LIFESTYLES AND PREVENTIVE HEALTHCARE
9.5 REST OF THE WORLD
9.5.1 GROWING PREVALENCE OF CHRONIC DISEASES
9.5.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
9.5.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPANY RANKING: TELOMERE TESTING MARKET
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE BENCHMARKING
10.4.1 BUSINESS STRATEGIES EXCELLENCE
10.4.2 STRENGTH OF PRODUCT PORTFOLIO
*Top 25 companies analyzed for this study are - Genova Diagnostics; Quest Diagnostics; Life Length; Zimetry LLC; Telomere Diagnostics; Repeat Diagnostics; SpectraCell Laboratories; Cell Science Systems; Titanovo, Inc.; InsideTracker; DNA LABS India; Laboratory Corporation of America Holdings; Cleveland HeartLab, Inc.; BioReference Laboratories; Immundiagnostik AG; Spectra Laboratories; Cell Biolabs Inc.; AML Diagnostics; Enzo Clinical Lab; Access Medical Labs; Life Line Screening; Mayo Medical Laboratories; Clinical Reference Labotory; Synlab Internatinal; ACM Medical Laboratory
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships)*
11.1 TELOMERE DIAGNOSTICS, INC. (TDX)
11.2 SPECTRACELL LABORATORIES
11.3 LIFE LENGTH
11.4 REPEAT DIAGNOSTICS INC. (REPEAT DX)
11.5 TITANOVO
11.6 CELL SCIENCE SYSTEMS
11.7 QUEST DIAGNOSTICS
11.8 LABCORP HOLDINGS
11.9 BIOREFRENCE LABORATORIES
11.10 CLEVELAND HEARTLAB, INC.
11.11 GENOVA DIAGNOSTICS
11.12 ZIMETRY LLC
11.13 IMMUNDIAGNOSTIK AG
11.14 SEGTERRA, INC.
11.15 DNA LABS INDIA
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY AT BIRTH, BY REGION (YEARS)
Table 2 LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY FOR INDIVIDUALS AGED 60 YEARS, BY REGION (YEARS)
Table 3 GOVERNMENT INITIATIVES TO PROMOTE LIFE SCIENCE RESEARCH
Table 4 INITIATIVES FROM PRIVATE ORGANIZATIONS TO PROMOTE LIFE SCIENCE RESEARCH
Table 5 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
Table 6 SINGLE TEST PANELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
Table 7 SINGLE TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 8 NORTH AMERICA: SINGLE TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 9 TELOMERE TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 10 NORTH AMERICA: TELOMERE TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 11 OXIDATIVE STRESS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 12 NORTH AMERICA: OXIDATIVE STRESS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 13 DEVELOPMENTS IN THE INFLAMMATION TESTS MARKET
Table 14 INFLAMMATION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 15 NORTH AMERICA: INFLAMMATION TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 16 HEAVY METALS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 17 NORTH AMERICA: HEAVY METALS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 18 MULTI-TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 19 NORTH AMERICA: MULTI-TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 20 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
Table 21 DEVELOPMENTS IN THE BLOOD TESTS MARKET
Table 22 CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY REGION, 2015-2022 (USD MILLION)
Table 23 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 24 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 25 ASIA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 26 CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2015-2022 (USD MILLION)
Table 27 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 28 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 29 ASIA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 30 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
Table 31 CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
Table 32 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 33 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 34 CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
Table 35 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 36 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 37 GLOBAL CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY REGION, 2015-2022 (USD MILLION)
Table 38 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 39 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 40 CELLULAR HEALTH SCREENING MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 41 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 43 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 44 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 45 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 46 U.S.: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 47 U.S.: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 48 U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 49 U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 50 CANADA: RESEARCH ACTIVITIES IN THE FIELD OF CELLULAR HEALTH
Table 51 CANADA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 CANADA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 53 CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 54 CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 55 EUROPE: IMPORTANT EVENTS FOCUSING ON CELLULAR BIOMARKERS
Table 56 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 57 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 58 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 59 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 60 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 61 ASIA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 62 ASIA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 63 ASIA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 64 ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 65 ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 66 ROW: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 67 ROW: CELLULAR HEALTH SCREENING MARKET FOR SINGLE-TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 68 ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 69 ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 70 RANKING OF TOP PLAYERS IN THE TELOMERE TESTING MARKET
Table 71 REPEAT DX: LIST OF ACCREDITATIONS
Table 1 LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY AT BIRTH, BY REGION (YEARS)
Table 2 LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY FOR INDIVIDUALS AGED 60 YEARS, BY REGION (YEARS)
Table 3 GOVERNMENT INITIATIVES TO PROMOTE LIFE SCIENCE RESEARCH
Table 4 INITIATIVES FROM PRIVATE ORGANIZATIONS TO PROMOTE LIFE SCIENCE RESEARCH
Table 5 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015-2022 (USD MILLION)
Table 6 SINGLE TEST PANELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
Table 7 SINGLE TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 8 NORTH AMERICA: SINGLE TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 9 TELOMERE TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 10 NORTH AMERICA: TELOMERE TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 11 OXIDATIVE STRESS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 12 NORTH AMERICA: OXIDATIVE STRESS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 13 DEVELOPMENTS IN THE INFLAMMATION TESTS MARKET
Table 14 INFLAMMATION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 15 NORTH AMERICA: INFLAMMATION TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 16 HEAVY METALS TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 17 NORTH AMERICA: HEAVY METALS TESTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 18 MULTI-TEST PANELS MARKET, BY REGION, 2015-2022 (USD MILLION)
Table 19 NORTH AMERICA: MULTI-TEST PANELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 20 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
Table 21 DEVELOPMENTS IN THE BLOOD TESTS MARKET
Table 22 CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY REGION, 2015-2022 (USD MILLION)
Table 23 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 24 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 25 ASIA: CELLULAR HEALTH SCREENING MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 26 CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2015-2022 (USD MILLION)
Table 27 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 28 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 29 ASIA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 30 GLOBAL CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015-2022 (USD MILLION)
Table 31 CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
Table 32 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 33 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 34 CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY REGION, 2015-2022 (USD MILLION)
Table 35 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SIZE FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 36 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR IN-OFFICE SAMPLE COLLECTION, BY COUNTRY, 2015-2022 (USD MILLION)
Table 37 GLOBAL CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY REGION, 2015-2022 (USD MILLION)
Table 38 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 39 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR OTHER SAMPLE COLLECTION SITES, BY COUNTRY, 2015-2022 (USD MILLION)
Table 40 CELLULAR HEALTH SCREENING MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 41 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 42 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 43 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 44 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 45 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 46 U.S.: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 47 U.S.: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 48 U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 49 U.S.: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 50 CANADA: RESEARCH ACTIVITIES IN THE FIELD OF CELLULAR HEALTH
Table 51 CANADA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 CANADA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 53 CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 54 CANADA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 55 EUROPE: IMPORTANT EVENTS FOCUSING ON CELLULAR BIOMARKERS
Table 56 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 57 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 58 EUROPE: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 59 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 60 EUROPE: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 61 ASIA: CELLULAR HEALTH SCREENING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
Table 62 ASIA: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 63 ASIA: CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 64 ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 65 ASIA: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 66 ROW: CELLULAR HEALTH SCREENING MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 67 ROW: CELLULAR HEALTH SCREENING MARKET FOR SINGLE-TEST PANELS, BY TYPE, 2015–2022 (USD MILLION)
Table 68 ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
Table 69 ROW: CELLULAR HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITE, 2015–2022 (USD MILLION)
Table 70 RANKING OF TOP PLAYERS IN THE TELOMERE TESTING MARKET
Table 71 REPEAT DX: LIST OF ACCREDITATIONS
LIST OF FIGURES
Figure 1 GLOBAL CELLULAR HEALTH SCREENING: MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 KEY DATA FROM SECONDARY SOURCES
Figure 4 KEY DATA FROM PRIMARY SOURCES
Figure 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 8 DATA TRIANGULATION METHODOLOGY
Figure 9 CELLULAR HEALTH SCREENING MARKET SIZE, BY TYPE, 2017 VS. 2022 (USD MILLION)
Figure 10 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2017 VS. 2022 (USD MILLION)
Figure 11 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017 VS. 2022 (USD MILLION)
Figure 12 NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 13 RISING FOCUS TOWARDS PREVENTIVE HEALTHCARE IS EXPECTED TO DRIVE THE GLOBAL CELLULAR HEALTH SCREENING MARKET
Figure 14 AT-HOME SAMPLE COLLECTION SEGMENT TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 15 MULTI-TEST PANELS SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
Figure 16 INFLAMMATION TESTS TO COMMAND THE LARGEST SHARE OF THE CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS IN 2017
Figure 17 BLOOD SAMPLES SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
Figure 18 ASIAN MARKET PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 19 CELLULAR HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
Figure 20 SINGLE TEST PANELS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 21 BLOOD SAMPLES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 22 AT-HOME SAMPLE COLLECTION SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 23 NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 25 PREVALENCE OF CORONARY HEART DISEASE BY AGE AND SEX (2009–2012)
Figure 26 EUROPE: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 27 ASIA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 28 ROW: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 29 GLOBAL CELLULAR HEALTH SCREENING MARKET, COMPETITIVE LEADERSHIP MAPPING 2017
Figure 30 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2016)
Figure 31 LABCORP HOLDINGS: COMPANY SNAPSHOT (2016)
Figure 32 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2016)
Figure 1 GLOBAL CELLULAR HEALTH SCREENING: MARKET SEGMENTATION
Figure 2 RESEARCH DESIGN
Figure 3 KEY DATA FROM SECONDARY SOURCES
Figure 4 KEY DATA FROM PRIMARY SOURCES
Figure 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 8 DATA TRIANGULATION METHODOLOGY
Figure 9 CELLULAR HEALTH SCREENING MARKET SIZE, BY TYPE, 2017 VS. 2022 (USD MILLION)
Figure 10 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE TYPE, 2017 VS. 2022 (USD MILLION)
Figure 11 CELLULAR HEALTH SCREENING MARKET SIZE, BY SAMPLE COLLECTION SITE, 2017 VS. 2022 (USD MILLION)
Figure 12 NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 13 RISING FOCUS TOWARDS PREVENTIVE HEALTHCARE IS EXPECTED TO DRIVE THE GLOBAL CELLULAR HEALTH SCREENING MARKET
Figure 14 AT-HOME SAMPLE COLLECTION SEGMENT TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 15 MULTI-TEST PANELS SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
Figure 16 INFLAMMATION TESTS TO COMMAND THE LARGEST SHARE OF THE CELLULAR HEALTH SCREENING MARKET FOR SINGLE TEST PANELS IN 2017
Figure 17 BLOOD SAMPLES SEGMENT TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
Figure 18 ASIAN MARKET PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 19 CELLULAR HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
Figure 20 SINGLE TEST PANELS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 21 BLOOD SAMPLES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 22 AT-HOME SAMPLE COLLECTION SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 23 NORTH AMERICA TO DOMINATE THE CELLULAR HEALTH SCREENING MARKET DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 25 PREVALENCE OF CORONARY HEART DISEASE BY AGE AND SEX (2009–2012)
Figure 26 EUROPE: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 27 ASIA: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 28 ROW: CELLULAR HEALTH SCREENING MARKET SNAPSHOT
Figure 29 GLOBAL CELLULAR HEALTH SCREENING MARKET, COMPETITIVE LEADERSHIP MAPPING 2017
Figure 30 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2016)
Figure 31 LABCORP HOLDINGS: COMPANY SNAPSHOT (2016)
Figure 32 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2016)
